ストックスクリーナーアプリを入手
0.84
9.09%
0.07
プレマーケット:
.85
0.01
+1.19%
前日終値:
$0.77
開ける：
$0.7745
24時間の取引高:
298.31K
Relative Volume:
0.22
時価総額：
$26.54M
収益：
$1.22M
当期純損益:
$-22.43M
株価収益率:
-0.7264
EPS:
-1.1564
ネットキャッシュフロー:
$-18.78M
1週間 パフォーマンス:
+9.06%
1か月 パフォーマンス:
+25.28%
6か月 パフォーマンス:
+40.94%
1年 パフォーマンス:
-31.15%
1日の値動き範囲:
$0.7625
$0.85
1週間の範囲:
$0.7536
$0.85
52週間の値動き範囲:
$0.475
$1.80
Longeveron Inc Stock (LGVN) Company Profile
Compare LGVN vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
0.84 | 24.96M | 1.22M | -22.43M | -18.78M | -1.1564 |
VRTX
Vertex Pharmaceuticals Inc
|
458.99 | 114.33B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
607.93 | 64.47B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
892.26 | 54.99B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
282.72 | 38.42B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
157.77 | 34.03B | 742.00K | -1.37B | -1.07B | -7.0731 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-06 | 開始されました | ROTH MKM | Buy |
Longeveron Inc (LGVN) 最新ニュース
Longeveron receives SME status from European regulator By Investing.com - Investing.com Nigeria
Longeveron receives SME status from European regulator - Investing.com UK
Longeveron Granted SME Status by European Medicines Agency - Moomoo
Longeveron Inc. Awarded SME Status by European Medicines Agency, Enhancing Drug Development Opportunities - Quiver Quantitative
Biotech Longeveron wins EMA SME status, where SME drugs saw 89% OKs - Stock Titan
LGVN Shares Rise After Investigational Therapy Shows Improvement In Age-Related Frailty Study - Stocktwits
Number of shareholders of Longeveron Inc. – BOATS:LGVN - TradingView
LGVN Q1 2026 Earnings: Deeper Losses Weigh on Shares as Clinical Progress ContinuesGross Profit Margin - newsline.com
Longeveron Announces CFO Transition to Internal Successor - TipRanks
LongeveronOn June 1, Lisa Locklear To Step Down As CFO Effective July 10, 2026SEC Filing - TradingView
Longeveron (NASDAQ: LGVN) CFO Lisa Locklear to step down, controller eyed as successor - Stock Titan
Longeveron to Present at BIO International Convention 2026 - BioSpace
Stem cell firm Longeveron seeks Alzheimer’s, heart partners at BIO 2026 - Stock Titan
LGVN Q1 2026 Earnings: EPS Misses Estimates as Clinical-Stage Biotech Continues R&D AdvancesShare Repurchase Impact - newsline.com
LGVN Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Clinical-Stage Biotech Navigates Costs - newsline.com
Longeveron Inc. (LGVN) Q1 2026 Earnings: Wider-Than-Expected Loss Pressures SharesEarnings Trend Analysis - The Legal Advocate
Longeveron Inc. (LGVN) Extends Decline: Tests Key Support at $0.74 After 4.9% DropDebt Free Companies - newsline.com
Longeveron (LGVN) Stock Forecast & Analyst Ratings - Moomoo
Longeveron Inc. Q1 2026 Earnings: EPS Misses Estimates Despite Stock RallyAdjusted Earnings Analysis - newsline.com
LGVN stock slips after hours as FDA flags concerns on rare heart defect trial design - MSN
LGVN Should I Buy - Intellectia AI
Longeveron CEO outlines strategy ahead of August trial data - Investing.com India
Longeveron CEO outlines strategy ahead of August trial data By Investing.com - Investing.com Nigeria
Longeveron Inc. (LGVN) Edges Higher Amid Stabilization at $0.72Dividend Growth Stocks - The Legal Advocate
[ARS] Longeveron Inc. SEC Filing - Stock Titan
Longeveron (NASDAQ: LGVN) plans reverse split, bigger share pool and incentive plan - Stock Titan
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering ... - Caledonian Record
Longeveron Issues Letter to Stockholders Highlighting - GlobeNewswire
Longeveron anticipates August 2026 ELPIS II readout while shifting to an asset-light partnering model - MSN
Earnings call transcript: Longeveron Q1 2026 reveals strategic shift By Investing.com - Investing.com Nigeria
Earnings call transcript: Longeveron Q1 2026 reveals strategic shift - Investing.com
[SCHEDULE 13G] Longeveron Inc. Passive Investment Disclosure (>5%) - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Longeveron Earnings Call: Trial Milestones Amid FDA Hurdles - TipRanks
Longeveron Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Longeveron Inc (LGVN) 財務データ
収益
当期純利益
現金流量
EPS
2.60%
0.94%
大文字化:
|
ボリューム (24 時間):